Lokakarya Pembahasan Pedoman WHO untuk HIV dan Hepatitis

/, Panduan & Kebijakan, Perpustakaan/Lokakarya Pembahasan Pedoman WHO untuk HIV dan Hepatitis

WHO baru-baru ini merilis sejumlah pedoman baru terkait Hepatitis dan HIV, serta sejumlah pembaruan terkait perawatan. Untuk program HIV, pedoman dan pemutakhiran termasuk:
1. Pedoman untuk mengelola penyakit HIV lanjut dan inisiasi ART
2. Pembedaan perawatan berdasarkan kondisi tertentu
3. Transisi ke ARV baru dalam program HIV
4. Pelaksanaan PrEP (Profilaksis Pre Pajanan)
5. Pembaruan dalam pemantauan penqobatan, tes Viral Load dan CD4
6. Pedoman tes HIV mandiri dan rujukan kepada pasangan

Pada saat yang sama, Kementerian Kesehatan Republik Indonesia juga sedang memperbarui pedoman nasional tentang layanan tes HIV dan pedoman pengobatah. Ada juga rencana dari pemangku kepentingan untuk melakukan studi dalam pelaksanaan layanan PrEP, dan upaya untuk menerapkan serta memperluas akses hingga pemantauan pengobatan. Sebagai bagian dari komitmen negara untuk pencapaian target melalui jalur cepat ada kebutuhan bagi pemangku kepentingan untuk mendapatkan penjelasan tentang pedoman terbaru dari WHO dan rencana aksi regional guna memperkuat rencana aksi dan implementasi program di tingkat nasional.

Materi-materi dalam lokakarya tersebut dapat diunduh pada tautan di bawah ini:

Advanced Disease and Rapid ART initiation, oleh Dr. B.B. Rewari, WHO Regional office for South-East Asia, New Delhi

What is new in HIV Treatment, oleh Dr. B.B. Rewari, WHO Regional office for South-East Asia, New Delhi

CD4 and Viral load update, oleh oleh Dr. B.B. Rewari, WHO Regional office for South-East Asia, New Delhi

Combination Prevention: A Global Concept that can be considered in Indonesia, oleh Fábio Mesquita

Key recommendations from WHO SEARO Think Tank meeting on “Revisiting strategies for intervention among Key populations for HIV”, oleh Dr. B.B. Rewari, WHO Regional office for South-East Asia, New Delhi

Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-world cohort in Brazil after the implementation of Dolutegravir, oleh Meireles MV, Pascom ARP, Perini F, Rick F, Benzaken A., Ministry of Health of Brazil, Department of STI, AIDS and Viral Hepatitis

GLOBAL ACTION PLAN ON HIV DRUG RESISTANCE 2017–2021: 2018 PROGRESS REPORT

CASCADE DATA USE MANUAL TO IDENTIFY GAPS IN HIV AND HEALTH SERVICES FOR PROGRAMME IMPROVEMENT

GLOBAL ACTION PLAN ON HIV DRUG RESISTANCE 2017-2021

GLOBAL GUIDANCE ON CRITERIA AND PROCESSES FOR VALIDATION: ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV AND SYPHILIS

GUIDELINES FOR MANAGING ADVANCED HIV DISEASE AND RAPID INITIATION OF ANTIRETROVIRAL THERAPY

GUIDELINES FOR THE DIAGNOSIS, PREVENTION AND MANAGEMENT OF CRYPTOCOCCAL DISEASE IN HIV-INFECTED ADULTS, ADOLESCENTS AND CHILDREN

GUIDELINES ON THE PUBLIC HEALTH RESPONSE TO PRETREATMENT HIV DRUG RESISTANCE

HIV DRUG RESISTANCE REPORT 2017

NOVEL POINT-OF-CARE TOOLS FOR EARLY INFANT DIAGNOSIS OF HIV

GUIDELINES FOR MANAGING ADVANCED HIV DISEASE AND RAPID INITIATION OF ANTIRETROVIRAL THERAPY

GUIDELINES FOR THE DIAGNOSIS, PREVENTION AND MANAGEMENT OF CRYPTOCOCCAL DISEASE IN HIV-INFECTED ADULTS, ADOLESCENTS AND CHILDREN

START FREE, STAY FREE, AIDS FREE: A SUPER-FAST-TRACK FRAMEWORK FOR ENDING AIDS AMONG CHILDREN, ADOLESCENTS AND YOUNG WOMEN BY 2020

UPDATE ON ANTIRETROVIRAL REGIMENS FOR TREATING AND PREVENTING HIV INFECTION AND UPDATE ON EARLY INFANT DIAGNOSIS OF HIV

WHAT’S NEW IN TREATMENT MONITORING: VIRAL LOAD AND CD4 TESTING

WHO IMPLEMENTATION TOOL FOR MONITORING THE TOXICITY OF NEW ANTIRETROVIRAL AND ANTIVIRAL MEDICINES IN HIV AND VIRAL HEPATITIS PROGRAMMES